deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT03739476

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

Controlled, Double-blind, Randomized Clinical Trial for Prophylaxis of Postoperative Delirium in High Risk Surgical Patients With Quetiapine

Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Updated 10 times since 2018 Last updated: May 21, 2025 Started: Feb 13, 2019 Primary completion: Apr 2, 2020 Completion: Jun 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to the crisis SARS-COV-2 pandemic: recruitment of patients for the trial is stopped, healthcare pressure generated, suspend the non-essential scheduled surgical activity and on June 30, 2020 medication expired, funding has been exhausted.

Other terminated trials from Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

See all terminations from Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

This PHASE3 trial investigates Postoperative Delirium and is currently terminated or withdrawn. Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2019 – ~Jan 2020 · 12 months · monthly snapshotRecruiting~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotRecruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshotTerminated~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotTerminated~Jun 2025 – present · 13 months · monthly snapshotTerminated

Change History

10 versions recorded
  1. Jun 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Jun 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jul 2022 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Dec 2021 — Jul 2022 [monthly]

    Terminated PHASE3

Show 5 earlier versions
  1. Feb 2021 — Dec 2021 [monthly]

    Terminated PHASE3

    Status: RecruitingTerminated

  2. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  3. Jan 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  4. Jan 2019 — Jan 2020 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  5. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
  • Grupo Español de Rehabilitación Multimodal
  • Instituto de Investigación Biomédica de Salamanca
Data source: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations